Related Experiment Video
Updated: May 22, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Retinoids: novel immunomodulators and tumour-suppressive agents?
M R Carratù1, C Marasco, G Mangialardi
1Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy.
British Journal of Pharmacology
|May 15, 2012
Summary
Retinoids regulate cell activity and show potential as treatments for immune disorders like type I diabetes and lupus, as well as for cancer therapy.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Retinoids are crucial for regulating gene transcription in various cell types, including normal, degenerative, and cancerous cells.
- Retinoid analogues have emerged as potential therapeutic candidates for a range of immune-mediated diseases.
- Significant advancements in retinoid-based cancer therapy have been observed over the past two decades.
Purpose of the Study:
- To discuss the current and prospective applications of retinoids.
- To highlight the role of retinoids as immunomodulators.
- To explore the potential of retinoids as tumor-suppressive agents.
Main Methods:
- Literature review of retinoid research.
- Analysis of retinoid compounds' synthesis and testing.
- Discussion of clinical and preclinical data on retinoid efficacy.
Main Results:
- Retinoids demonstrate significant immunomodulatory effects relevant to autoimmune diseases.
- Retinoid compounds show promise in cancer treatment, with numerous agents developed and evaluated.
- The therapeutic potential of retinoids spans both immune system regulation and cancer suppression.
Conclusions:
- Retinoids are versatile molecules with established roles in cellular processes.
- Retinoid analogues offer a promising therapeutic avenue for immune disorders and cancer.
- Further research into retinoid mechanisms and applications is warranted for clinical translation.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...